CUTIA-B 02487Hong Kong Stock Exchange

0.7858.19%( -0.070 )
Closed: Oct 12 · Delayed · Hong Kong Stock Exchange
CUTIA-B (02487) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2023-06-12
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG2606C1006

Industry

Innovative Drugs & Biologics 1.38%
124 stocks in this industry
Down 78 Up 36
Industry RankingsValue (HKD)Rank
Revenue (Last FY)394.15M72/112
Net Profit (Last FY)-398.88M101/125
ROE (Last FY)-38.43%95/117

Change is the 2026-10-12 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
张乐乐 Executive Director
黄雨青 Executive Director
陈连勇 Non-Executive Director
谢沁 Non-Executive Director
卢敏放 Non-Executive Director
杨云霞 Non-Executive Director
钟明杰 Independent Non-Executive Director
张志嵩 Independent Non-Executive Director
叶晓翔 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-12-30.

About this page

This page shows CUTIA-B (02487) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.